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Abstract
Hypertrophic scarring, a common proliferative disorder of dermal fibroblasts, results from an overproduction of fibroblasts
and excessive deposition of collagen. Although treatment with surgical excision or steroid hormones can modify the
symptoms, numerous treatment-related complications have been described. In view of this, we investigated the therapeutic
effects of essential oil (EO) from rhizomes of Ligusticum chuanxiong Hort. (Umbelliferae) on formed hypertrophic scars in a
rabbit ear model. EO was prepared as a liposomal formulation (liposome-enveloped essential oil, LEO) and a rabbit ear
model with hypertrophic scars was established. LEO (2.5, 5, and 10%) was applied once daily to the scars for 28 days. On
postoperative day 56, the scar tissue was excised for masson’s trichrome staining, detection of fibroblast apoptosis, assays
of the levels of collagens I and III, and analysis of the mRNA expression of matrix metalloproteinase-1 (MMP-1), caspase-3
and -9, and transforming growth factor beta 1 (TGF-b1). In addition, the scar elevation index (SEI) was also determined. As a
result, LEO treatment significantly alleviated formed hypertrophic scars on rabbit ears. The levels of TGF-b1, MMP-1, collagen
I, and collagen III were evidently decreased, and caspase -3 and -9 levels and apoptosis cells were markedly increased in the
scar tissue. SEI was also significantly reduced. Histological findings exhibited significant amelioration of the collagen tissue.
These results suggest that LEO possesses the favorable therapeutic effects on formed hypertrophic scars in the rabbit ear
model and may be an effective cure for human hypertrophic scars.
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Introduction
Hypertrophic scarring generally occurs following surgery,
trauma and especially burns, which is a common proliferative
disorder of dermal fibroblasts and results from an overproduction
of collagen and excessive deposition of extracellular matrix [1].
Patients with hypertrophic scars often report itching and pain, and
experience serious functional and cosmetic problems, which are
caused by a variety of complications, including compression,
sensation of stiffness, loss of joint mobility and anatomical
deformities [2,3].
When a deep wound or an exuberant scar occurs, there are
many preventive and therapeutic measures such as silicone,
pressure therapy, corticosteroids, laser therapy, cryotherapy,
radiation, surgery, and some new methods developed such as
interferon and 5-fluorouracil. However, there is no consensus
about the best treatment to produce complete and permanent
improvement of scars with few side effects [4,5].
Natural drugs have been generally recognized to play a unique
therapeutic rolein the treatment of many diseases [6–9]. Essential oils
from many plant species have become especially popular in recent
years, and investigations into their bioactivities and mechanisms of
action have been performed for human health [10,11].
Rhizoma Chuanxiong, the rhizome of Ligusticum chuanxiong
Hort. (Umbelliferae) and one of the well-known traditional
Chinese medicines, is warm in property and pungent in flavor
and possesses efficacy in promoting the circulation of the blood
and qi, expelling wind, and alleviating pain, which has high
medicinal value. It has been used in the clinical treatment of pain,
migraine, rheumatic arthralgia, inflammation, menstrual distur-
bance, and cardiovascular and cerebrovascular diseases for nearly
2000 years [12–14]. The volatile compounds in this herbal drug
are considered an important part of its pharmacological effects
mentioned above. There are several investigations reported
suggesting that the essential oil (EO) from this plant could protect
against DNA damage and apoptosis induced by ultraviolet B in
mammalian cells [15]. The Ethyl ether extract blocks endothelial
cell damage induced by hydrogen peroxide [16]. The anti-
Trichophyton effects of Ligusticum chuanxiong essential oil are also
validated [17].
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extracted from the plant markedly suppressed the viability of
human hypertrophic scar fibroblasts (HSFs), elicited cell apoptosis
in vitro [18], and inhibited hypertrophic scar formation in the
rabbit ear model [19], suggesting its preventive effects on
hypertrophic scarring. Nevertheless the good preventive effect of
a drug does not mean its favorable therapeutic action. As far as we
are aware no investigators have reported the therapeutic effects of
EO on produced hypertrophic scars. This study was designed to
demonstrate whether EO could alleviate or eliminate formed
hypertrophic scars in the rabbit ear model and to explore the
possible mechanism of action.
Results
LEO inhibits the formation of collagen I and collagen III
Collagens, including collagen I and collagen III, are the most
important ingredients of ECM. As shown in Figure 1A and 1B, the
levels of collagens I and III were significantly increased in the
control group when compared with the normal group. By contrast,
in the LEO treatment groups, the levels of collagens I and III
decreased dramatically after 28 days of the treatment with LEO,
and in the highest group, the levels of collagens I and III were even
lower than those in the contractubex group.
mRNA levels of MMP1, TGF-b1, caspase-3 and caspase-9
MMP1 and TGF-b1 play important roles in the formation of
scars. Their mRNA expression levels significantly ascended in the
control group in comparison with the normal group, but markedly
decreased in the groups treated with the doses of 2.5, 5, and 10%
LEO for 28 days (Figue 2A and 2B). Activation of caspase-3 and
caspase-9 can evidently induce apoptosis of the hypertrophic
fibroblasts. In this study, their mRNA expression levels were
reduced in the control group when compared with the normal
group, while increased dramatically and dose-dependently in the
treatment groups given the doses of 2.5, 5, and 10% LEO for 28
days (Figure 2C and 2D).
Quantification of TUNEL positive cells
Sections from rabbit ears subjected to liposomes with or without
EO or contractubex were stained for visualization of fragmented
DNA, which indicated apoptosis cells. One of the characteristics of
hypertrophic scarring is abnormal proliferation of dermal
fibroblasts, but LEO significantly induced apoptosis of scar
fibroblasts in this study. As shown in Figure 3, the ratio of
TUNEL positive cells in the control group was higher than that in
the normal group, indicating an increase in apoptosis of scar
fibroblasts, but significantly lower than that in the groups treated
with the doses of 2.5, 5, and 10% LEO for 28 days, suggesting that
LEO elicited more apoptosis of scar fibroblasts.
Scar elevation index
On day 56 post-wounding, there was significant hypertrophic
scarring in the control group with the mean scar elevation index
(SEI) of 2.7460.24 (Figure 4). Successive administration of LEO
for 28 days since day 29 post-wounding markedly and dose-
dependently inhibited scar hyperplasia in the treatment groups
with the mean SEI of 2.3960.21, 1.9660.20, and 1.3460.11,
respectively. SEI in the highest group (10% LEO) was even lower
than that in the contractubex group (1.5360.17).
Masson’s trichrome staining findings
Overproduction of collage is another characteristic of hyper-
trophic scars. Masson staining of scar tissue was carried out on day
56 post-wounding. Light microscopic examination revealed typical
features of collagen fibers in scar tissue (Figure 5B) in the control
group compared with unwounded dermal tissue (Figure 5A). The
collagen bundles were thicker, denser, disorganized and more
abundant. By contrast, collage fibers were decreased, thinner and
more regularly ranged in the groups treated with LEO, which
found dose dependent (Figure 5D–F).
Discussion
Generally researchers are apt to investigate the preventive
effects of natural drugs on hypertrophic scar formation, but it dose
not reflect their therapeutic actions authentically. After all, drugs
are more commonly used to treat formed hypertrophic scars
clinically and the good preventive effect of a drug does not mean
its favorable therapeutic action. Therefore we further investigated
the therapeutic effect of the essetial oil (EO) from Ligusticum
chuanxiong on formed hypertrophic scars in the rabbit ear model on
the basis of our previous preliminary investigations [18,19] for a
show of its clinical value.
Liposomes are artificially prepared vesicles made of lipid
bilayer, which can be filled with drugs, and have been extensively
employed to enhance the efficiency of drug delivery via several
routes of administration. liposomes can facilitate deposition of
drugs into the skin and significantly enhance the accumulation of
drugs at the site of administration as a result of the high
substantivity of liposomes with biological membranes. liposomal
drug formations have been substantiated to be markedly superior
to conventional dosage forms, especially for the topical mode of
administration of drugs [20]. Thus the essential oil (EO) was
prepared as a liposomal formulation (LEO) for use in this study.
The rabbit ear model with hypertrophic scars was first
established by Morris et al. in 1997 [21]. After that this model
was modified further by many researchers [22–24] for its transient
hypertrophy. Currently this model provides reproducible cutane-
ous hypertropic scars which are in parallel with human scar on the
whole in gross appearance and histological features lasting over 3
months, and are commonly used for the investigation of anti-
scarring modalities, such as steroid treatment, silicone occlusion,
and procollagen C-proteinase inhibitor therapy. Our previous
study showed significant scarring on the rabbit ears from
postoperative day 28 to day 56, which is similar to previous
reports [22–24], so the drug treatment was carried out duing this
period in the model rabbits in the present study.
Hypertrophic scarring is characterized by overproduction of
fibroblasts and excessive deposition of collagen. Hypertrophic scar
fibroblasts (HSFs) have a higher capacity for proliferation, cytokine
production, and collagen synthesis than normal fibroblasts [25].
Therefore, inhibitory proliferation or induction of apoptosis in
fibroblasts is an important treatment for hypertrophic scarring. Our
previous study indicated that EO markedly induced apoptosis of
HSFs from human skin tissue [19]. In the present study, in situ
detection of cell apoptosis was performed to further substantiate
whether LEO facilitated HSFs apoptosis in scar tissue. It is
interesting that the ratio of TUNEL positive cells had a significant
increase inLEO treatment groups compared with the control group,
suggesting that LEO induced more apoptosis of scar fibroblasts.
Collagen, secreted mainly by fibroblasts, is the main component
of extracellular matrix (ECM) and the principal structural protein
holding the skin. Collagen dysmetabolism is the pathological basis
of hypertrophic scarring [26,27] and is also a common cause of
fibrotic diseases. Normal fibroblasts synthesize both collagen I and
collagen III, but this synthesis becomes imbalanced with changes
in the surrounding environment. The immature and instable type
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healing, while the predominant collagen type in skin is the mature
and mechanically stable type I collagen [28]. During granulation
tissue formation, type III collagen expression increases more than
the type I expression [29], but much of type III collagen is
replaced later by the stronger and tougher type I collagen. Our
results also demonstrated that the amount of type I collagen was
more than that of type III collagen in the formed hypertrophic scar
tissue of the model rabbit ears on postoperative day 56. LEO
dramatically and dose-dependently suppressed types I and III
collagen protein synthesis in the hypertrophic scar tissue of the
rabbit ears. Pathological examination also showed that collagen
fibers evidently decreased in LEO treatment groups compared
with the control group.
We further observed the mRNA expression levels of matrix
metalloproteinase-1 (MMP-1), transforming growth factor beta 1
Figure 1. Effects of liposome-enveloped essential oil (LEO) on the levels of collagens I (A) and III (B). The levels of collagens I and III in
the control group significantly increased after 56 postoperative days when compared with the normal group. The treatment with LEO for 28 days
decreased the levels of collagens I and III dramatically and dose-dependently in comparison with the control group. DD P,0.01 compared with the
normal group; **P,0.01 compared with the control group. Data are expressed as the mean 6 SD. n=12.
doi:10.1371/journal.pone.0031157.g001
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tion of fibroblasts and excessive deposition of collagen. Wound
repair involves cell migration, proliferation, and tissue remodeling.
These ordered and regulated processes are facilitated by matrix-
degrading proteases. Collagenase is the only known enzyme able
to start the breakdown of the interstitial collagens (types I, II and
III). MMP-1 plays a key role in the remodelling that occurs
constantly in both unwounded and diseased conditions [30], and is
the key enzyme in the degradation of type I and type III collagens
in scars. There is considerable evidence that a number of cytokines
are important components in the process of wound healing and
scar formation. One of the most intensively investigated molecules
associated with many types of fibrosis is TGF-b1, which stimulates
infiltration of inflammatory cells and fibroblasts, and induces
fibroblast proliferation, angiogenesis and synthesis of ECM, while
a persistent autocrine loop of TGF-b1 contributes to hypertrophic
scar formation [31]. In this study, the expression of MMP-1 and
TGF-b1 was significantly increased in the control group of scar
tissue. It seems inconsistent in terms of their effects. Presumably
they maintained a dynamic balance at higher levels. Excessive
TGF-b1 facilitated overproduction of scar fibroblasts, while scar
fibroblasts further secreted more MMP-1 to degrade collagen
protein. LEO evidently decreased the expression levels of MMP-1
and TGF-b1 mainly by induction of apoptosis in scar fibroblasts.
Apoptotic cell death is mediated by molecular pathways that
culminate in the activation of a family of cysteine proteases, known
as the caspases, which orchestrate the dismantling and clearance of
dying cells [32,33]. There is considerable evidence demonstrating
that activation of caspase-9 and -3 has significant relationships
with scar fibroblast apoptosis. Caspase-3 activity has been
described to be essential for drug-induced apoptosis, and
caspase-9 is necessary for the process of apoptosis in scar
fibroblasts [34,35]. In the process of cell apoptosis, pro-caspase-9
is recruited to the ‘‘apoptosome’’ complex, while the recruitment
causes caspase-9 cleavage and further activates downstream
executioner caspases such as caspase-3 [36–38]. The activation
of caspase-9 and -3 via the release of cytochrome c can induce
apoptosis in scar fibroblasts in vivo [35,39]. In order to further
verify apoptosis in scar fibroblasts, we detected the mRNA
expression levels of caspase-3 and caspase-9. After treatment with
LEO for 28 days, the mRNA expression of caspase-3 and -9
increased markedly and dose-dependently compared with the
control group, suggesting that LEO facilitated fibroblast apoptosis
in scar tissue.
In a previous study, we also found that EO significantly
inhibited the growth of cultured HSFs, and induced cell apoptosis
[18]. Based on these findings, we deduce that LEO alleviates
formed hypertrophic scars mainly through inhibition of HSF
proliferation and induction of HSF apoptosis, as the abnormal
biological behaviour of fibroblasts plays a central role in
hypertrophic scar formation and development [40]. Fibroblasts
synthesize both type I and type III collagens, which are the main
components of the ECM, and also excrete TGF-b1 and MMP-1,
which regulate the synthesis and degradation of collagen.
In conclusion, LEO alleviates produced hypertrophic scars in
the rabbit ear model, mainly by inhibiting HSF proliferation and
inducing HSF apoptosis, which further downregulates the mRNA
expression of TGF-b1 and MMP-1, and upregulates degradation
of collagen types I and III. LEO is potentially an effective cure for
human hypertrophic scarring.
Figure 3. Effects of LEO on the ratio of TUNEL positive scar fibroblasts. After 56 postoperative days, the amount of TUNEL positive scar
fibroblasts in scar tissue markedly increased in the control group in comparison with the normal group. Nevertheless the treatment with LEO for 28
days evidently increased the number of TUNEL positive scar fibroblasts when compared with the control group. DDP,0.01 compared with the
normal group; *P,0.05, **P,0.01 compared with the control group. Data are expressed as the mean 6 SD. n=12.
doi:10.1371/journal.pone.0031157.g003
Figure 2. The changes of relative mRNA expression levels of MMP1, TGF-b1, caspase-3, and caspase-9. The mRNA expression levels of
MMP1 and TGF-b1 significantly increased in the control group after 56 postoperative days when compared with the normal group, while evidently
decreased in the groups treated with LEO for 28 days in comparison with the control group. On the other hand, the mRNA expression levels of
caspase-3 and caspase-9 in the control group decreased dramatically after 56 postoperative days when compared with the normal group. The
treatment with LEO for 28 days significantly increased the mRNA expression levels of caspase-3 and caspase-9 when compared with the control
group. DDP,0.01 compared with the normal group; **P,0.01 compared with the control group. Data are expressed as the mean 6 SD. n=12.
doi:10.1371/journal.pone.0031157.g002
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Ethics statement
All animal treatments were strictly in accordance with
international ethical guidelines and the National Institutes of
Health Guide concerning the Care and Use of Laboratory
Animals, and the experiments were carried out with the approval
of the Animal Experimentation Ethics Committee of the Second
Military Medical University.
Drug preparation
In accordance with our previous reports [18,19], the essential oil
(EO) was extracted and its chemical composition was analyzed by
GC-MS. Dozens of compounds were detected from EO and the
major components were ligustilide and butylidenephthalide with
relative contents of 67.027 and 5.831%, respectively. In this study, a
liposome formulation was used due to its favorable penetrability and
topical accumulation.Liposome-eneloped EO (LEO) was prepared by
Dr. Ying Lu, an associate Professor from Department of Pharma-
ceutics, School of Pharmacy, Second Military Medical University
(Shanghai, China), and empty liposomes were used as placebo.
Rabbit ear model of hypertrophic scar tissue
A previously reported hypertrophic scar rabbit model was used
in this study [41]. Six female New Zealand white rabbits,
(Shanghai Si-Lai-Ke Experimental Animal Co. Ltd., Shanghai,
China), with an initial body weight of 2.060.2 kg, were used.
Animals were housed in a regulated environment (2262uC), with
a 12 h light/dark cycle (light cycle was 08.00–20.00 h). Food and
water were given ad libitum throughout the experiment.
The animals were intravenously anaesthetized with sodium
pentobarbital 30 mg/kg. Under sterile conditions, six full-
thickness wounds were created down to the bare cartilage on
each ear using a biopsy punch. Each ear received six round
wounds, 10 mm in diameter, placed in a random order on the ear,
thus each rabbit had 12 wounds. The epidermis, dermis and
perichondrium in each wound were thoroughly removed, and the
wounds were covered with sterile gauze for 1 day. After recovery
from anaesthesia, the rabbits were returned to their cages.
Figure 5. Masson’s trichrome staining findings for collagen. (A)
Unwounded (normal) skin with regularly arranged, small collagen fibers.
(B) In the control group treated with empty liposomes, the amount of
collage fibers is far more than that in the normal group, and collage
fibers are thicker, denser and disorganized. (C) Contractubex. (D–F)
After treatment with (D) 2.5%, (E) 5% and (F) 10% LEO for 28 days, the
collagen fibers were arranged more regularly and sparse than those in
the control group. Original magnification 6400.
doi:10.1371/journal.pone.0031157.g005
Figure 4. LEO decreases scar elevation index. The degree of scar hypertrophy is reflected by scar elevation index (SEI), which represents the
ratio of total scar connective tissue area to the area of underlying dermis. After treatment with LEO for 28 days, the formed hypertrophic scars
decreased in a dose-dependent manner. *P,0.05, **P,0.01 versus the control group. Data are expressed as the mean 6 SD. n=12.
doi:10.1371/journal.pone.0031157.g004
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On postoperative day 29 and afterwards, scars were randomly
divided into five groups, with 12 scars to each group: one control
(placebo) group, three LEO treatment groups and one positive
group treated with contractubex, known to reduce exuberant
collagen production (Merz Pharma GmbH, Frankfurt, Germany).
The scars in the control group were thinly coated with liposomes
without EO once a day. LEO (2.5%, 5%, and 10%, w/v) was
applied once daily to the scars in the three treatment groups, and
contractubex to the scars in the positive group. One further
unwounded rabbit with full-thickness skin on its ears (Normal
group) was used as a further (unwounded) placebo, and received
neither liposomes (with or without EO) or contractubex.
Determination of collagen I and collagen III
All animals were killed on posttherapeutic day 28 (postoperative
day 56), the scar tissue was separated from the rest of the tissue,
and the cartilage removed. The weighed scar tissue was diced, and
rapidly frozen in liquid nitrogen until used. Once the tissue was
removed from the liquid nitrogen, it was maintained at 4uC after
thawing. To each 50 mg of tissue, 1 mL of phosphate-buffered
saline (pH 7.4) was added, then the tissue was homogenized and
separated by centrifugation at 3000 g and 4uC for 20 min, and the
supernatant was collected for assay.
Collagen I and collagen III were measured by ELISA using an
appropriate commercial ELISA kit for each, according to the
manufacturer’s instructions (R & D Systems Inc., Minneapolis,
MN, USA). Briefly, 40 mL of sample dilution and 10 mL of the
supernatant were added to a testing sample well, gently mixed,
and incubated for 30 min at 37uC after closing the microplate with
the membrane supplied with the kit, after which the membrane
was removed and the liquid in the well discarded. Washing buffer
was added to the well and left for 30 s, then drained. This
procedure was repeated five times, then 50 mL of horseradish
peroxidase-conjugated reagent was added to each well and
incubated for 30 min at 37uC, followed by washing five times
with washing buffer from the kit. Each well was incubated with
chromogen solution A (50 mL) and chromogen solution B (50 mL)
for 15 min at 37uC, and the stop solution (50 mL) added to each
well to terminate the reaction. The optical density was measured
at 450 nm using a microplate reader (ELx-800 Universal; Bio-Tek,
North Brunswick, NJ, USA).
RNA isolation and Fluorescent quantitative reverse
transcription-PCR (FQ-RT-PCR)
TriPure Isolation Reagent (Roche Diagnostics, Vilvoorde,
Belgium) was used to extract the total mRNA of the scar tissue
in accordance with our previous report (17), and the isolated RNA
was treated with RNase-free DNase (Promega). Reverse transcrip-
tion was performed using a cDNA synthesis kit according to the
manufacturer’s instructions (Applied Biosystem).
Primer pairs for rabbit genes (MMP1, TGF-b1,C a s p a s e - 3 ,C a s p a s e -
9) were designed using the Primer Express design software (Applied
Biosystems) and listed in Table 1. The house-keeping gene GAPDH
w asu s e da sa ni n t e r n a lc o nt r o l .F Q - R T - P C Rw a sp e r f o r m edo nar e al -
time PCR instrument (ABI 7900HT, Applied Biosystems) for 40 cycles
consisting of denaturation at 95uC for 30 s, annealing at 59uC for 30 s
and extension at 72uC for 30 s. All amplifications and detections were
carried out in a MicroAmp optical 384-well reaction plate with optical
adhesive covers (Applied Biosystems). Relative expression of mRNA
(%)=2
2DCT(1,2,3,4)6100%, where CT represents threshold cycle,
DCT1=CT (MMP1)2CT(GAPDH), DCT2=CT (TGF-b1)2CT(GAPDH),
DCT3=CT (Caspase-3)2CT(GAPDH), DCT4=CT (Caspase-9)2CT(GAPDH)
Detection of apoptotic cells by TUNEL assay
For in situ detection of DNA fragmentation in paraffin-
embedded tissue sections, the TUNEL method was performed
using the TUNEL Apoptosis Detection Kit (KeyGen Biotech Co.,
Nanjing, China), following manufacturer’s instructions. Briefly, the
tissue sections were deparaffinized with dimethylbenzene, rehy-
drated through gradient ethanol immersion, and then incubated in
working solution comprising 2 mL5 0 6proteinase K and 98 mL
PBS for 20 min at room temperature for Protein digestion.
Endogenous peroxidase was inactivated with 3% H2O2 in
methanol for 10 min at room temperature. The reaction fluid
containing dUTP and TdT enzyme was added to the sections and
incubated at 37uC in a humified chamber for 1 h. The sections
were rinsed with PBS 3 times, appended 50 mL streptavidin-HRP
treatment fluid, and incubated for 30 min at 37uC in a humified
chamber. Following rinsing with PBS 3 times, the sections were
incubated in working solution containing diaminobenzidine and
3% H2O2 for 10 min. Finally, the sections were washed with PBS,
counterstained in haematoxylin, dehydrated and observed in a
light microscope. The positive cells were counted and evaluated as
the ratio of TUNEL-positive cells to a total number of fibroblast
cells.
Determination of SEI
Scar tissue with cartilage was fixed with 10% buffered formalin
for 3 days, embedded in paraffin, sectioned with a dermatome,
and stained using hematoxylin–eosin (H&E). Light microscopy
was used to examine the degree of scar hyperplasia, which was
expressed as the scar elevation index (SEI). SEI represents the ratio
of the scar tissue height to the normal tissue below the
hypertrophic scar. A ratio of 1 indicates no difference in the
wound area height compared with unwounded skin.
Masson’s trichrome staining for collagen fibers
Scar tissue was fixed with 10% formalin, embedded in paraffin,
sectioned and stained with Masson’s Trichrome Stain Kit
following the manufacturer’s instructions (KeyGen Biotech Co.,
Nanjing, China). Briefly, the tissue sections were deparaffinized
with dimethylbenzene, rehydrated through gradient ethanol
immersion, and washed in running water for 5 minutes. The
tissue was stained in Weigert’s iron hematoxylin working solution
for 10 minutes before rinsing the sections for 5 minutes in running
water and washing them in distilled water. The slides were stained
in Biebrich scarlet-acid fuchsin solution for 5 minutes, washed in
Table 1. Primers used in real-time RT-PCR analysis.
Gene Primer sequence Species Amplicon size (bp)
MMP1 S:59ttccaaagcagagaggcaat 39 Rabbit 84
A:59gcttcccagtcactttcagc 39
TGF-b1 S: 59 acattgacttccgcaaggac 39 Rabbit 104
A: 59 gtccaggctccagatgtagg 39
Caspase-3 S: 59 tgccatgctgaaagagtacg 39 Rabbit 104
A: 59 tggcatcaagggaataggac 39
Caspase-9 S: 59 ccaggtggatgctgtgtcta 39 Rabbit 170
A: 59 gcagggactgtaggtcttcg 39
GAPDH S: 59 caacgaatttggctacagca 39 Rabbit 183
A: 59 ctgtgaagaggggcagattc 39
doi:10.1371/journal.pone.0031157.t001
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tungstic acid solution for 5 minutes. Subsequently, the sections
were transferred directly into aniline blue solution, stained for
5 minutes, and rinsed in 1% acetic acid solution for 2 minutes.
Finally, the tissue was dehydrated, cleared, and mounted.
Collagen fibers were stained in blue.
Statistical analysis
All results were presented as the mean 6 SD. Data were
analyzed using a SPSS 13.0 statistical package. Data for multiple
comparisons were performed by one-way ANOVA followed by
Dunnett’s test. A value of P,0.05 was considered statistically
significant.
Acknowledgments
We thank Xue-Qin Ma, Kun He, Li-Ya Han, Yan Zhang for their
assistance with establishment of the animal model and specimen collection.
We also thank Zhi-Yi Shao (Shanghai Daweike Biotechnology Co., Ltd) for
excellent technical assistance with FQ-RT-PCR assays.
Author Contributions
Conceived and designed the experiments: LPQ CP. Performed the
experiments: HZ XR CLH YL. Analyzed the data: HZ XR. Contributed
reagents/materials/analysis tools: HZ XR LPQ CP. Wrote the paper: HZ
XR.
References
1. O’Leary R, Wood EJ, Guillou PJ (2002) Pathological scarring: strategic
interventions. Eur J Surg 168: 523–534.
2. Bock O, Schmid-Ott G, Malewski P, Mrowietz U (2006) Quality of life of
patients with keloid and hypertrophic scarring. Arch Dermatol Res 297:
433–438.
3. Mazharinia N, Aghaei S, Shayan Z (2007) Dermatology Life Quality Index
(DLQI) scores in burn victims after revival. J Burn Care Res 28: 312–317.
4. Reish RG, Eriksson E (2008) Scar treatments: preclinical and clinical studies.
J Am Coll Surg 206: 719–730.
5. Bloemen MCT, van der Veer WM, Ulrich MMW, van Zuijlen PPM,
Niessen FB, et al. (2009) Prevention and curative management of hypertrophic
scar formation. Burns 35: 463–475.
6. Zhang H, Xing WW, Li YS, Zhu Z, Wu JZ, et al. (2008) Effects of a traditional
Chinese herbal preparation on osteoblasts and osteoclasts. Maturitas 61:
334–339.
7. Du J, Sun LN, Xing WW, Huang BK, Jia M, et al. (2009) Lipid-lowering effects
of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters.
Phytomedicine 16: 652–658.
8. Wu JG, Wu JZ, Sun LN, Han T, Du J, et al. (2009) Ameliorative effects of
arctiin from Arctium lappa on experimental glomerulonephritis in rats.
Phytomedicine 16: 1033–1041.
9. Xing WW, Wu JZ, Jia M, Du J, Zhang H, et al. (2009) Effects of polydatin from
Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits. Biomed
Pharmacother 63: 457–462.
10. Zhang H, Han T, Yu CH, Rahman K, Qin LP, et al. (2007) Ameliorating effects
of essential oil from Acori graminei rhizoma on learning and memory in aged
rats and mice. J pharm pharmacol 59: 301–309.
11. Zhang H, Han T, Zhang L, Yu CH, Wan DG, et al. (2008) Effects of tenuifolin
extracted from radix polygalae on learning and memory: A behavioral and
biochemical study on aged and amnesic mice. Phytomedicine 15: 587–594.
12. China Pharmacopoeia Committee (2005) Chinese Pharmacopoeia, Vol. 1.
Beijing: Chemical Industry Press 2005. 28 p.
13. Chan SSK, Choi AOK, Jones RL, Lin G (2006) Mechanisms underlying the
vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum
chuanxiong, in rat isolated aorta. Euro J Pharmacol 537: 111–117.
14. Peng C, Xie XF, Wang L, Guo L, Hu TL (2009) Pharmacodynamic action and
mechanism of volatile oil from rhizoma Ligustici Chuanxiong Hort. on treating
headache. Phytomedicine 16: 25–34.
15. Jeong JB, Ju SY, Park JH, Lee JR, Yun KW, et al. (2009) Antioxidant activity in
essential oils of Cnidium officinale Makino and Ligusticum chuanxiong Hort. and their
inhibitory effects on DNA damage and apoptosis induced by ultraviolet B in
mammalian cell. Cancer Epidemiol 33: 41–46.
16. Hou YZ, Zhao GR, Yang J, Yuan JY, Zhu GG, et al. (2004) Protective effect of
Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by
hydrogen peroxide. Life Sci 75: 1775–1786.
17. Sim Y, Shin S (2008) Combinatorial anti-Trichophyton effects of Ligusticum
chuanxiong essential oil components with antibiotics. Arch Pharm Res 31:
497–502.
18. Wu JG, Ma L, Zhang SY, Zhu ZZ, Zhang H, et al. (2011) Essential oil from
rhizomes of Ligusticum chuanxiong induces apoptosis in hypertrophic scar
fibroblasts. Pharm Biol 49: 86–93.
19. Wu JG, Wei YJ, Ran X, Zhang H, Nian H, et al. (2011) Inhibitory effects of
essential oil from rhizomes of Ligusticum chuanxiong on hypertrophic scarring
in the rabbit ear model. Pharm Biol 49: 764–769.
20. Egbaria K, Weiner N (1990) Liposomes as a topical drug delivery system. Adv
Drug Deliver Rev 5: 287–300.
21. Morris DE, Wu L, Zhao LL, Bolton L, Roth SI, et al. (1997) Acute and chronic
animal models for excessive dermal scarring: quantitative studies. Plast Reconstr
Surg 100: 674–681.
22. Niu F, Niu Y, Chen Y (2004) Establishment of rabbits hypertrophic scars model.
China Medical Engineering 12: 12–15.
23. Song B, ZhangW, Guo S, Han Y, Zhang Y, et al. (2009) Adenovirus-mediated
METH1 gene expression inhibits hypertrophic scarring in a rabbit ear model.
Wound Rep Reg 17: 559–568.
24. Yu R, Song Y, Chen JJ, Liu XX, Cen Y (2010) Establishment of an animal
model of rabbit’s ear with intermediate stage hypertrophic scar. West China
Medical Journal 25: 1209–1212.
25. Niessen FB, Spauwen PH, Schalkwijk J, Kon M (1999) On the nature of
hypertrophic scars and keloids: A review. Plast Reconstr Surg 104: 1435–1458.
26. Clark J, Cheng J, Leung K (1996) Mechanical properties of normal skin and
hypertrophic scars. Burns 22: 443–446.
27. Beldon P (2000) Abnormal scar formation in wound healing. Nursing times 96:
44.
28. Schaffer M, Becker HD (1999) Immune regulation of wound healing. Der
Chirurg 70: 897–908.
29. Hayakawa T, Hashimoto Y, Myokei Y, Aoyama H, Izawa Y (1979) Changes in
type of collagen during the development of human post-burn hypertrophic scars.
Clin Chim Acta 93: 119–125.
30. Dasu MR, Hawkins HK, Barrow RE, Xue H, Herndon DN (2004) Gene
expression profiles from hypertrophic scar fibroblasts before and after IL-6
stimulation. J Pathol 202: 476–485.
31. Schmid P, Itin P, Cherry G, Bi C, Cox DA (1998) Enhanced expression of
transforming growth factor-beta type I and type II receptors in wound
granulation tissue and hypertrophic scar. Am J Pathol 152: 485–93.
32. Cande C, Vahsen N, Garrido C, Kroemer G (2004) Apoptosis-inducing factor
(AIF): caspase-independent after all. Cell Death Differ 11: 591–595.
33. Chipuk JE, Green DR (2005) Do inducers of apoptosis trigger caspase-
independent cell death? Nat Rev Mol Cell Biol 6: 268–275.
34. Pirnia F, Schneider E, Betticher D, Borner M (2002) Mitomycin C induces
apoptosis and caspase-8 and-9 processing through a caspase-3 and Fas-
independent pathway. Cell Death Differ 9: 905.
35. Akasaka Y, Ito K, Fujita K, Komiyama K, Ono I, et al. (2005) Activated caspase
expression and apoptosis increase in keloids: cytochrome c release and caspase-9
activation during the apoptosis of keloid fibroblast lines. Wound Repair Regen
13: 373–382.
36. Rodriguez J, Lazebnik Y (1999) Caspase-9 and APAF-1 form an active
holoenzyme. Gene Dev 13: 3179–3184.
37. Wang XD (2001) The expanding role of mitochondria in apoptosis. Gene Dev
15: 2922–2933.
38. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770–776.
39. Wu M, Xu LG, Li X, Zhai Z, Shu HB (2002) AMID, an apoptosis-inducing
factor-homologous mitochondrion-associated protein, induces caspase-indepen-
dent apoptosis. J Biol Chem 277: 25617.
40. Tuan TL, Nichter LS (1998) The molecular basis of keloid and hypertrophic
scar formation. Mol Med Today 4: 19–24.
41. Kryger ZB, Sisco M, Roy NK, Lu L, Rosenberg D, et al. (2007) Temporal
expression of the transforming growth factor-beta pathway in the rabbit ear
model of wound healing and scarring. J Am Coll Surgeons 205: 78–88.
Chuanxiong Oil Alleviates Scar Hyperplasia
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31157